☰

Erin L. Winstanley, Ph.D. - Publications

Affiliations: 
2006 Johns Hopkins University, Baltimore, MD 
Area:
Public Health
Tree Info Similar researchers PubMed Report error

32/71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zheng W, Cavrak M, Bowles H, Deng Y, Wen S, Gao S, Lander L, Berry J, Winstanley EL. 10-year retention of a comprehensive treatment model of buprenorphine for opioid use disorder. Journal of Addictive Diseases. 1-8. PMID 38400724 DOI: 10.1080/10550887.2024.2315366  0.317
2024 Lundstrom EW, Dai Z, Groth CP, Hendricks B, Winstanley EL, Abate M, Smith GS. Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study. Substance Abuse Treatment, Prevention, and Policy. 19: 4. PMID 38178238 DOI: 10.1186/s13011-023-00587-2  0.33
2020 Mahoney JJ, Winstanley EL, Lander LR, Berry JH, Marshalek PJ, Haut MW, Marton JL, Kimble WD, Armistead M, Wen S, Cai Y, Hodder SL. High prevalence of co-occurring substance use in individuals with opioid use disorder. Addictive Behaviors. 114: 106752. PMID 33348147 DOI: 10.1016/j.addbeh.2020.106752  0.338
2020 Stover AN, Rockett IRH, Smith GS, LeMasters T, Scott VG, Kelly KM, Winstanley EL. Feasibility and acceptability of safety screening among patients receiving addiction treatment. Journal of Substance Abuse Treatment. 117: 108092. PMID 32811626 DOI: 10.1016/J.Jsat.2020.108092  0.433
2020 Hines KL, Garofoli GK, Garofoli MP, Elswick BM, Winstanley EL. Impact of naloxone education for patients receiving buprenorphine-containing prescriptions indicated for opioid use disorder at an independent community pharmacy. Journal of the American Pharmacists Association : Japha. PMID 32800678 DOI: 10.1016/J.Japh.2020.07.015  0.428
2020 Winstanley EL, Mahoney JJ, Lander LR, Berry JH, Marshalek P, Zheng W, Haut MW. Something to despair: Gender differences in adverse childhood experiences among rural patients. Journal of Substance Abuse Treatment. 116: 108056. PMID 32741501 DOI: 10.1016/J.Jsat.2020.108056  0.334
2020 Winstanley EL. The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic. The International Journal On Drug Policy. 102796. PMID 32499119 DOI: 10.1016/J.Drugpo.2020.102796  0.3
2020 Lander LR, Zheng W, Hustead JD, Mahoney JJ, Berry JH, Marshalek P, Winstanley EL. Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program. Journal of the Neurological Sciences. 411: 116712. PMID 32058182 DOI: 10.1016/J.Jns.2020.116712  0.42
2019 Winstanley EL, Stover AN, Feinberg J. Concurrent Alcohol and Opioid Use Among Harm Reduction Clients. Addictive Behaviors. 100: 106027. PMID 31683186 DOI: 10.1016/J.Addbeh.2019.06.016  0.402
2019 Winstanley EL, Stover AN. The impact of the opioid epidemic on children and adolescents. Clinical Therapeutics. PMID 31303278 DOI: 10.1016/J.Clinthera.2019.06.003  0.401
2019 Winstanley EL, Lander LR, Berry JH, Mahoney JJ, Zheng W, Herschler J, Marshalek P, Sayres S, Mason J, Haut MW. West Virginia's model of buprenorphine expansion: Preliminary results. Journal of Substance Abuse Treatment. PMID 31221524 DOI: 10.1016/J.Jsat.2019.05.005  0.396
2018 Penm J, MacKinnon NJ, Connelly C, Mashni R, Lyons MS, Hooker EA, Winstanley EL, Carlton-Ford S, Tolle E, Boone J, Koechlin K, Defiore-Hyrmer J. Emergency Physicians' Perception of Barriers and Facilitators for Adopting an Opioid Prescribing Guideline in Ohio: A Qualitative Interview Study. The Journal of Emergency Medicine. PMID 30342861 DOI: 10.1016/J.Jemermed.2018.09.005  0.406
2018 Penm J, MacKinnon NJ, Mashni R, Lyons MS, Hooker EA, Winstanley EL, Carlton-Ford S, Connelly C, Tolle E, Boone J, Koechlin K, Defiore-Hyrmer J. Statewide cross-sectional survey of emergency departments' adoption and implementation of the Ohio opioid prescribing guidelines and opioid prescribing practices. Bmj Open. 8: e020477. PMID 29961010 DOI: 10.1136/Bmjopen-2017-020477  0.396
2018 Winstanley EL, Zhang Y, Mashni R, Schnee S, Penm J, Boone J, McNamee C, MacKinnon NJ. Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. Drug and Alcohol Dependence. 188: 169-174. PMID 29778769 DOI: 10.1016/J.Drugalcdep.2018.03.036  0.418
2017 Winstanley EL, Mashni R, Schnee S, Miller N, Mashni SM. The development and feasibility of a pharmacy-delivered opioid intervention in the emergency department. Journal of the American Pharmacists Association : Japha. 57: S87-S91. PMID 28292506 DOI: 10.1016/J.Japh.2017.01.021  0.365
2017 Penm J, MacKinnon NJ, Boone JM, Ciaccia A, McNamee C, Winstanley EL. Strategies and policies to address the opioid epidemic: A case study of Ohio. Journal of the American Pharmacists Association : Japha. PMID 28189539 DOI: 10.1016/J.Japh.2017.01.001  0.33
2016 Butler MM, Ancona RM, Beauchamp GA, Yamin CK, Winstanley EL, Hart KW, Ruffner AH, Ryan SW, Ryan RJ, Lindsell CJ, Lyons MS. Emergency Department Prescription Opioids as an Initial Exposure Preceding Addiction. Annals of Emergency Medicine. PMID 26875061 DOI: 10.1016/J.Annemergmed.2015.11.033  0.427
2016 Winstanley EL, Clark A, Feinberg J, Wilder CM. Barriers to implementation of opioid overdose prevention programs in Ohio. Substance Abuse. 37: 42-6. PMID 26682929 DOI: 10.1080/08897077.2015.1132294  0.403
2015 Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD. Risk Factors for Opioid Overdose and Awareness of Overdose Risk Among Veterans Prescribed Chronic Opioids for Addiction or Pain. Journal of Addictive Diseases. 0. PMID 26566771 DOI: 10.1080/10550887.2016.1107264  0.378
2015 Clark A, Winstanley EL, Martsolf DS, Rosen M. Implementation of an inpatient opioid overdose prevention program. Addictive Behaviors. 53: 141-145. PMID 26517710 DOI: 10.1016/J.Addbeh.2015.10.006  0.399
2015 Winstanley EL, Clark A, Wilder CM. Response to "Quality Assessment Errors and Study Misclassification Threaten Systematic Review Validity: Community Opioid Overdose Prevention and Naloxone Distribution Programs Review". Journal of Addiction Medicine. 9: 503-4. PMID 26517326 DOI: 10.1097/Adm.0000000000000160  0.339
2015 Winstanley EL, Clark AK, Feinberg J. Implementation of nasal naloxone across health-care settings: a case report from Ohio Addiction Science & Clinical Practice. 10. DOI: 10.1186/1940-0640-10-S1-A72  0.414
2015 Winstanley EL, Clark A. Risk factors associated with overdose among patients seeking treatment for opioid dependence Drug and Alcohol Dependence. 146: e25. DOI: 10.1016/J.Drugalcdep.2014.09.748  0.391
2014 Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic. American Journal of Public Health. 104: 2023-9. PMID 25211712 DOI: 10.2105/Ajph.2014.302147  0.44
2014 Wilder CM, Brason FW, Clark AK, Galanter M, Walley AY, Winstanley EL. Development and implementation of an opioid overdose prevention program within a preexisting substance use disorders treatment center. Journal of Addiction Medicine. 8: 164-9. PMID 24874760 DOI: 10.1097/Adm.0000000000000032  0.428
2014 Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine. 8: 153-63. PMID 24874759 DOI: 10.1097/Adm.0000000000000034  0.407
2014 Winstanley EL, Brigham GS, Babcock D, Winhusen T. Improving treatment for opioid dependence: a perspective from the Ohio Valley node of the NIDA Clinical Trials Network. Progress in Community Health Partnerships : Research, Education, and Action. 8: 99-107. PMID 24859107 DOI: 10.1353/Cpr.2014.0002  0.419
2014 Umbricht A, DeFulio A, Winstanley EL, Tompkins DA, Peirce J, Mintzer MZ, Strain EC, Bigelow GE. Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial. Drug and Alcohol Dependence. 140: 92-100. PMID 24814607 DOI: 10.1016/J.Drugalcdep.2014.03.033  0.313
2012 Winstanley EL, Steinwachs DM, Stitzer ML, Fishman MJ. Adolescent Substance Abuse and Mental Health: Problem Co-Occurrence and Access to Services. Journal of Child & Adolescent Substance Abuse. 21: 310-322. PMID 24532964 DOI: 10.1080/1067828X.2012.709453  0.534
2012 Winstanley EL, Gay J, Roberts L, Moseley J, Hall O, Beeghly BC, Winhusen T, Somoza E. Prescription drug abuse as a public health problem in Ohio: a case report. Public Health Nursing (Boston, Mass.). 29: 553-62. PMID 23078426 DOI: 10.1111/J.1525-1446.2012.01043.X  0.338
2010 Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction (Abingdon, England). 105: 1669-76. PMID 20626723 DOI: 10.1111/J.1360-0443.2010.03015.X  0.381
2008 Winstanley EL, Steinwachs DM, Ensminger ME, Latkin CA, Stitzer ML, Olsen Y. The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug and Alcohol Dependence. 92: 173-82. PMID 17913396 DOI: 10.1016/J.Drugalcdep.2007.07.012  0.527
Low-probability matches (unlikely to be authored by this person)
2016 Clark A, Breitenstein S, Martsolf DS, Winstanley EL. Assessing Fidelity of a Community-Based Opioid Overdose Prevention Program: Modification of the Fidelity Checklist. Journal of Nursing Scholarship : An Official Publication of Sigma Theta Tau International Honor Society of Nursing / Sigma Theta Tau. 48: 371-377. PMID 27376347 DOI: 10.1111/Jnu.12221  0.297
2012 Winhusen T, Winstanley EL, Somoza E, Brigham G. The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co-occurring substance use disorder and PTSD. Drug and Alcohol Dependence. 120: 225-8. PMID 21752556 DOI: 10.1016/J.Drugalcdep.2011.06.014  0.294
2011 Winstanley EL, Bigelow GE, Silverman K, Johnson RE, Strain EC. A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients. Journal of Substance Abuse Treatment. 40: 255-64. PMID 21266301 DOI: 10.1016/J.Jsat.2010.11.010  0.292
2006 Winstanley EL, Gust SW, Strathdee SA. Drug abuse and HIV/AIDS: international research lessons and imperatives. Drug and Alcohol Dependence. 82: S1-5. PMID 16769437 DOI: 10.1016/S0376-8716(06)80001-3  0.284
2019 Stover AN, Winstanley EL, Zhang Y, Feinberg J. The Impact of Rural Classification Systems on a Comparison of Risky Drug-Related Behaviors in Kentucky and Ohio Counties. Journal of Human Behavior in the Social Environment. 29: 301-307. PMID 31551652 DOI: 10.1080/10911359.2018.1516591  0.279
2022 Bommersbach T, Justen M, Bunting AM, Funaro MC, Winstanley EL, Joudrey PJ. Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review. The International Journal On Drug Policy. 112: 103931. PMID 36563489 DOI: 10.1016/j.drugpo.2022.103931  0.276
2011 McElroy SL, Guerdjikova AI, Winstanley EL, O'Melia AM, Mori N, McCoy J, Keck PE, Hudson JI. Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial. The International Journal of Eating Disorders. 44: 81-90. PMID 21080416 DOI: 10.1002/Eat.20876  0.276
2011 McElroy SL, Guerdjikova AI, Winstanley EL, O'Melia AM, Mori N, Keck PE, Hudson JI. Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study. The International Journal of Eating Disorders. 44: 262-8. PMID 20209489 DOI: 10.1002/Eat.20798  0.271
2021 Davis SM, Stover AN, Linn H, Dower J, McCawley D, Winstanley EL, Feinberg J. Establishing Peer Recovery Support Services to Address the Central Appalachian Opioid Epidemic: The West Virginia Peers Enhancing Education, Recovery, and Survival (WV PEERS) Pilot Program. Journal of Appalachian Health. 3: 36-50. PMID 35770037 DOI: 10.13023/jah.0303.04  0.27
2012 Guerdjikova AI, McElroy SL, Winstanley EL, Nelson EB, Mori N, McCoy J, Keck PE, Hudson JI. Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. The International Journal of Eating Disorders. 45: 281-9. PMID 21744377 DOI: 10.1002/Eat.20946  0.266
2011 McElroy SL, Winstanley EL, Martens B, Patel NC, Mori N, Moeller D, McCoy J, Keck PE. A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance. International Clinical Psychopharmacology. 26: 48-53. PMID 20861739 DOI: 10.1097/Yic.0B013E3283400D35  0.257
2018 Winstanley EL, Stroup-Menge B, Snyder K. The Promise of Technology-Based Services for Addiction Treatment Clients Residing in Nonurban Areas. Journal of Studies On Alcohol and Drugs. 79: 503-504. PMID 29885160 DOI: 10.15288/Jsad.2018.79.503  0.256
2020 Winstanley EL. Od: Naloxone And The Politics Of Overdose Addiction. DOI: 10.1111/Add.15212  0.254
2008 Babor TF, Winstanley EL. The world of drinking: national alcohol control experiences in 18 countries. Addiction (Abingdon, England). 103: 721-5. PMID 18412749 DOI: 10.1111/J.1360-0443.2008.02183.X  0.25
2010 McElroy SL, Martens BE, Winstanley EL, Creech R, Malhotra S, Keck PE. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania. Journal of Affective Disorders. 124: 157-63. PMID 19963274 DOI: 10.1016/J.Jad.2009.11.014  0.247
2012 McElroy SL, Winstanley E, Mori N, Martens B, McCoy J, Moeller D, Guerdjikova AI, Keck PE. A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain. Journal of Clinical Psychopharmacology. 32: 165-72. PMID 22367654 DOI: 10.1097/Jcp.0B013E3182488758  0.244
2015 Rosa C, Campbell AN, Miele GM, Brunner M, Winstanley EL. Using e-technologies in clinical trials. Contemporary Clinical Trials. PMID 26176884 DOI: 10.1016/J.Cct.2015.07.007  0.244
2016 Winstanley EL. Tangled-up and blue: releasing the regulatory chokehold on take-home naloxone. Addiction (Abingdon, England). 111: 583-4. PMID 26995167 DOI: 10.1111/Add.13255  0.237
2021 Wang K, DiChiacchio T, Fang W, Lander L, Feinberg J, Xie C, Winstanley EL, Ubolrat Piamjariyakul. Longitudinal study of impact of medication for opioid use disorder on Hamilton Depression Rating Scale. Journal of Affective Disorders. PMID 34670131 DOI: 10.1016/j.jad.2021.10.018  0.235
2021 Zhang Y, Castracane AR, Winstanley EL. Assessment of gabapentin misuse using prescription drug monitoring program data. Substance Abuse. 1-10. PMID 33689673 DOI: 10.1080/08897077.2021.1891602  0.233
2020 Winstanley EL, Baugh GM, Garofoli M, Muzyk AJ. Experiences and opinions of health professional students participating in an opioid use disorder educational event. The Mental Health Clinician. 10: 49-54. PMID 32257732 DOI: 10.9740/mhc.2020.03.049  0.232
2017 Winstanley EL, Burtchin M, Zhang Y, Campbell P, Pahl J, Beck S, Bohenek W. Inpatient Experiences with MyChart Bedside. Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association. PMID 28328391 DOI: 10.1089/Tmj.2016.0132  0.224
2021 Winstanley EL, Mahoney JJ, Castillo F, Comer SD. Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review. Drug and Alcohol Dependence. 226: 108838. PMID 34271512 DOI: 10.1016/j.drugalcdep.2021.108838  0.221
2023 Dai Z, Abate MA, Winstanley E, Kraner JC, Lundstrom E, Mock AR, Smith GS. Quantifying a potential protective effect of buprenorphine on fatality risk during acute fentanyl exposures. Journal of Substance Use and Addiction Treatment. 158: 209252. PMID 38070651 DOI: 10.1016/j.josat.2023.209252  0.216
2022 Stover AN, Rockett IRH, Smith GS, LeMasters T, Scott VG, Kelly KM, Winstanley EL. Distinguishing clinical factors associated with unintentional overdose, suicidal ideation, and attempted suicide among opioid use disorder in-patients. Journal of Psychiatric Research. 153: 245-253. PMID 35841821 DOI: 10.1016/j.jpsychires.2022.06.039  0.202
2021 Liu S, Nwabueze C, Pan Y, Walter SM, Su B, Xu C, Winstanley EL, Wang K. Polysubstance Use, Mood Disorders, and Chronic Conditions With Anxiety in Opioid Patients. Western Journal of Nursing Research. 1939459211031988. PMID 34301163 DOI: 10.1177/01939459211031988  0.201
2023 Mahoney JJ, Winstanley EL, Castillo F, Luba R, Marton J, Alschuler DM, Liu Y, Comer SD. A pilot study investigating cognitive impairment associated with opioid overdose. Drug and Alcohol Dependence. 247: 109865. PMID 37094488 DOI: 10.1016/j.drugalcdep.2023.109865  0.2
2022 Winstanley EL, Thacker EP, Choo LY, Lander LR, Berry JH, Tofighi B. Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use. Drug and Alcohol Dependence Reports. 5: 100091. PMID 36844166 DOI: 10.1016/j.dadr.2022.100091  0.196
2010 Winstanley EL, Bolon SK, Fishman M. Treatment Outcomes for Addictive Disorders Addictive Disorders in Medical Populations. 575-601. DOI: 10.1002/9780470710449.ch37  0.149
2021 Wagner K, Zhong Y, Teshale E, White K, Winstanley EL, Hettema J, Thornton K, Bisztray B, Fiuty P, Page K. Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico. Drug and Alcohol Dependence. 220: 108527. PMID 33465605 DOI: 10.1016/j.drugalcdep.2021.108527  0.149
2020 Rosa C, Marsch LA, Winstanley EL, Brunner M, Campbell ANC. Using digital technologies in clinical trials: Current and future applications. Contemporary Clinical Trials. 106219. PMID 33212293 DOI: 10.1016/j.cct.2020.106219  0.132
2022 Gupta A, Shebl FM, Tong Y, Wagner K, Bassett IV, Page K, Winstanley EL. Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016-2018. Addiction Science & Clinical Practice. 17: 58. PMID 36266666 DOI: 10.1186/s13722-022-00340-3  0.126
2016 Thompson J, Heaton P, Kelton C, Lin A, Luder H, Winstanley E. GENERIC DRUG DISCOUNT PROGRAMS AND THEIR POTENTIAL IMPACT ON BARRIERS TO ACCESS IN PATIENTS WITH DIABETES OR HYPERTENSION Value in Health. 19: A209. DOI: 10.1016/J.Jval.2016.03.1273  0.125
2023 Wang K, Shafique S, Wang N, Walter SM, Xie X, Piamjariyakul U, Winstanley EL. Early-onset alcohol, tobacco, and illicit drug use with age at onset of hypertension: a survival analysis. Social Psychiatry and Psychiatric Epidemiology. PMID 38104055 DOI: 10.1007/s00127-023-02596-9  0.118
2023 Bailey BC, Cox S, Terris L, van Oppen D, Howsare J, Berry JH, Winstanley EL. Rural health care worker wellness during COVID-19: Compassion fatigue, compassion satisfaction & utilization of wellness resources. Plos One. 18: e0295020. PMID 38064476 DOI: 10.1371/journal.pone.0295020  0.094
2022 Winstanley EL. Through the Looking Glass: Crack Pipes, Crackpots, and Crazy Ideas on How to Reduce Drug-Related Harms. Journal of Studies On Alcohol and Drugs. 83: 623-624. PMID 35838442  0.088
2022 Tang Y, Abildso CG, Lilly CL, Winstanley EL, Rudisill TM. Risk Factors Associated With Driving After Marijuana Use Among US College Students During the COVID-19 Pandemic. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 36549978 DOI: 10.1016/j.jadohealth.2022.10.027  0.082
2020 Winstanley EL, Lander LR, Zheng W, Law KB, Six-Workman A, Berry JH. Rapid Transition of Individual and Group-based Behavioral Outpatient Visits to Telepsychiatry in Response to COVID-19. Journal of Addiction Medicine. PMID 33105168 DOI: 10.1097/ADM.0000000000000748  0.066
2015 Rosa C, Campbell ANC, Miele GM, Brunner M, Winstanley EL. Using e-technologies in clinical trials Contemporary Clinical Trials. DOI: 10.1016/j.cct.2015.07.007  0.061
Hide low-probability matches.